explore -WSS

explore

author：focus 2025-09-28 04:13:02 - browse：159

Person wearing a smart watch. -- first opinion coverage from STAT — Adobe

The Apple Watch has secured a new qualification from the Food and Drug Administration that could make the smartwatch an appealing tool for medical device companies hoping to illustrate the benefits of a common heart procedure.

Last week, the Apple Watch’s Atrial Fibrillation History feature became the first digital tool qualified under the Medical Device Development Tools (MDDT) program. Released in 2022, the feature estimates a user’s A-fib burden, or how much time they spend in atrial fibrillation, which is an irregular heart rhythm that can cause shortness of breath and fatigue, and is also linked to an increased risk of stroke.

The qualification means that FDA has determined in advance that sponsors can use the feature as a secondary endpoint in clinical trials without having to do additional work. Specifically, the Apple Watch is qualified for use as a secondary endpoint in clinical trials for cardiac ablation devices, which reduce the electrical signals that cause A-fib by scarring the heart with extreme heat or cold energy. Pulsed field ablation is the latest version of the technology, using a controlled electric field to scar tissue rather than the riskier thermal energy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Humana sues Biden admin over Medicare Advantage audit rule

hotspot

WSS

Study: New antibiotic targets gonorrhea as well as last existing drug

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

A clever new way to fix Medicaid and graduate medical education

HPV cancer vaccine study demonstrates efficacy

Trump surgeon general acknowledges mistakes during Covid

knowledge

explore

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

knowledge

Peter Hotez and the public health issue of online harassment

Snackable artificial intelligence, expert AI, and the pharma industry

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

A rare thyroid diagnosis led to unexpected, all

FDA approval of Sarepta Duchenne genetic therapy gives me hope

NIH nominee Bertagnolli will get October confirmation hearing

Medicare proposal to cover medical devices draws a mixed reaction

10 million people disenrolled from Medicaid over past six months

ChatGPT in medicine: STAT answers readers' burning questions

Listen: Biogen's potential pivot, & Illumina's next chapter

Wikipedia

A new House health package & hospitals’ new site

Why Novartis is changing the name of its research labs

A clever new way to fix Medicaid and graduate medical education

A rare thyroid diagnosis led to unexpected, all

The new shift in health care is toward less care

Abortion clinic in Cancun will cater to Americans

focus

hotspot

hotspot

hotspot